Godlike Productions - Reply to Thread

Users Online Now: 1,974 (Who's On?)	Visitors Today: 643,089
Pageviews Today: 1,102,369	Threads Today: 347	Posts Today: 6,940
11:19 AM

Back to Thread

REPLY TO THREAD

Subject Covid: Blood thinner ineffective for patients, trial finds - Addenbrooke's Hospital and University of Cambridge

User Name

Font color: Font:

In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.

Original Message A possible treatment for severe Covid "puts patients at risk for no clear benefit", a trial found.

More than 1,000 people took part in the UK-wide trial of the blood thinner Apixaban while in hospital with Covid.

The Addenbrooke's Hospital and University of Cambridge study aims to find a treatment to prevent death from Covid, and readmission to hospital.

It found the drug had no impact, but some patients did experience side effects including major bleeding.

Dr Mark Toshner, joint chief investigator for the trial, said it had been assumed that Apixaban could help patients recover from severe Covid.

"This trial is the first robust evidence that longer anticoagulation after acute Covid-19 puts patients at risk for no clear benefit," he said.

"Our hope is that these results will stop this drug being needlessly prescribed to patients with Covid-19 and we can change medical practice."

[link to www.bbc.co.uk (secure)]

They are really panicking now.

Pictures (click to insert)